肌酐与胱抑素C比值作为社区老年女性肌少症指标与跌倒风险的生物标志物
结果显示,Cr:Cyc最低四分位组(Q1)相比最高组(Q4)握力弱5%(1.0 kg),ALM/身高²低3.7%(0.22 kg/m²),ALM/BMI低5.5%(0.031),且5年跌倒风险(HR 1.50;95%CI 1.11-2.01)和12年跌倒相关住院风险(HR 1.53;95%CI 1.13-2.07)均更高。结论支持进一步研究Cr:Cyc作为肌肉生物标志物以识别跌倒高风险个体。
要点
- Cr:Cyc最低四分位组握力较最高组弱5%(1.0 kg),ALM/身高²低3.7%。
- Cr:Cyc最低组5年跌倒风险增加50%(HR 1.50;95%CI 1.11-2.01)。
- Cr:Cyc最低组12年跌倒相关住院风险增加53%(HR 1.53;95%CI 1.13-2.07)。
核心结论
- Cr:Cyc与社区老年女性肌少症指标及跌倒风险相关,支持其作为肌肉生物标志物进一步研究。
主要发现
- 多变量调整模型中,Cr:Cyc最低四分位组(Q1)相比最高组(Q4)握力弱5%(1.0 kg),ALM/身高²低3.7%(0.22 kg/m²),ALM/BMI低5.5%(0.031),均p<.05。
- 5年内329名女性报告发生跌倒,12年内记录326例跌倒相关住院。
- Q1组相比Q4组5年跌倒的相对风险HR为1.50(95%CI 1.11-2.01),12年跌倒相关住院HR为1.53(95%CI 1.13-2.07)。
临床怎么用
- Cr:Cyc或可帮助临床医生识别跌倒高风险个体,以便早期纳入针对饮食和运动的循证一级预防项目。
局限性
- ALM/身高²仅在部分女性(n=334)中获取,基线及1年测量。
- 跌倒为自报结局,可能存在报告偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ratio of creatinine to cystatin C (Cr:Cyc) has been proposed as a biomarker of sarcopenia, as greater Cr:Cyc is typically associated with greater muscle mass. We examined the relationship between Cr:Cyc with individual sarcopenia measures, 5-year self-reported falls, and 12-year fall-related hospitalizations in a prospective cohort study of 1 118 community-dwelling older women (mean age 75.2 ± 2.7 years). METHODS: Serum Cr:Cyc, hand grip strength, and timed-up-and-go performance were assessed at baseline (1998), while dual-energy x-ray absorptiometry-derived appendicular lean mass (ALM)/height2 (m) was obtained in a subset of women at baseline and 1 year (n = 334). Incident 5-year self-reported falls and 12-year falls-related hospitalizations were considered. RESULTS: In a multivariable-adjusted model, women with the lowest Cr:Cyc (Quartile [Q] 1) had 5% (1.0 kg) weaker grip strength, as well as 3.7% (0.22 kg/m2) and 5.5% (0.031) lower ALM adjusted for height2 or body mass index, respectively, compared to women in Q4 (all p < .05). 329 women reported an incident fall over 5 years, and 326 fall-related hospitalizations were recorded over 12 years. Women in Q1 of Cr:Cyc had a greater relative hazard for a fall over 5 years (hazard ratio [HR] 1.50; 95% confidence interval [CI] 1.11-2.01) and fall-related hospitalization over 12 years (HR 1.53; 95% CI 1.13-2.07) compared to Q4 in the multivariable-adjusted model. CONCLUSION: These findings support further investigation into the use of Cr:Cyc as a muscle biomarker to help clinicians identify individuals at risk of falls for early inclusion into evidence-based primary prevention programs targeting improvements to diet and exercise.
引用
- Sim M, Dalla Via J, Scott D, et al. Creatinine to Cystatin C Ratio, a Biomarker of Sarcopenia Measures and Falls Risk in Community-Dwelling Older Women. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34907424. doi:10.1093/gerona/glab369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。